CD274 and lung carcinoma: Based on our findings regarding the PD‐L1 expression rates and pathological type distribution, the constitutive in vitro expression of PD‐L1 in lung cancer cell lines is basically consistent with the current therapeutic effects of blocking PD‐1/PD‐L1 clinically.